mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-07 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0006 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0009 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.002 |